Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of benralizumab in eosinophilic chronic rhinosinusitis with nasal polyps
CTR20200349Phase 3Terminated
- Sponsor
- AstraZeneca
- Start
- Jul 2020
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of benralizumab in chronic rhinosinusitis with nasal polyps (CRSwNP), sponsored by AstraZeneca. Started Jul 2020; status: terminated.
02
Drugs
benralizumab
03
Conditions
chronic rhinosinusitis with nasal polyps (CRSwNP)
Beyond the preview
Go deeper on CTR20200349.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200349.